From: Sheila

"The Manual of Clinical Psychopharmacology, first published in 1986, 
is the standard drug reference guide used by psychiatrists. The 
manual is written by three noted psychopharmacologists to provide 
clinical reviews and practical advice for the use of drugs in the 
treatment of psychiatric disease.

"The manual's discussion of Fanapt, which belongs to the class of 
drugs known as second-generation antipsychotics (SGA), is not all kind.
...
"Fanapt isn't the only new schizophrenia drug to launch in recent 
months. 
Merck(<http://www.thestreet.com/story/10761173/2//quote/MRK.html>MRK) 
is also now selling a drug known as Saphris. Both Fanapt and Saphris 
compete against existing schizophrenia drugs from Johnson & 
Johnson(<http://www.thestreet.com/story/10761173/2//quote/JNJ.html>JNJ), 
Pfizer(<http://www.thestreet.com/story/10761173/2//quote/PFE.html>PFE) 
and 
AstraZeneca(<http://www.thestreet.com/story/10761173/2//quote/AZN.html>AZN), 
as well as low-cost generics. "

http://bit.ly/d97eb2






Powered by LSoft's LISTSERV(R) list management software